Results 261 to 270 of about 28,208 (288)
Some of the next articles are maybe not open access.

Adipokines, adiposity, and atherosclerosis

Cellular and Molecular Life Sciences, 2022
Characterized by a surplus of whole-body adiposity, obesity is strongly associated with the prognosis of atherosclerosis, a hallmark of coronary artery disease (CAD) and the major contributor to cardiovascular disease (CVD) mortality. Adipose tissue serves a primary role as a lipid-storage organ, secreting cytokines known as adipokines that affect ...
Longhua, Liu   +6 more
openaire   +2 more sources

Adipokines and psoriasis

Experimental Dermatology, 2011
Abstract:  Adipose tissue is an active endocrine organ contributing to the regulation of multiple metabolic pathways via self‐produced bioactive products called adipokines. These adipokines are key players in the pathogenesis of metabolic syndrome and cardiovascular diseases.
Sascha, Gerdes   +2 more
openaire   +2 more sources

Adipobiology of Disease: Adipokines and Adipokine-Targeted Pharmacology

Current Pharmaceutical Design, 2003
In recent years, the simple paradigm of adipose tissue as merely a fat store is rapidly evolving into a complex paradigm of this tissue as multipotential secretory organ, partitioned into a few large depots, including visceral and subcutaneous location, and many small depots, associated with a variety of organs in the human body.
G N, Chaldakov   +3 more
openaire   +2 more sources

Obesity, adipokines and neuroinflammation

Neuropharmacology, 2015
Global levels of obesity are reaching epidemic proportions, leading to a dramatic increase in incidence of secondary diseases and the significant economic burden associated with their treatment. These comorbidities include diabetes, cardiovascular disease, and some psychopathologies, which have been linked to a low-grade inflammatory state.
Argel, Aguilar-Valles   +3 more
openaire   +2 more sources

Adipose‐derived exosomes: A novel adipokine in obesity‐associated diabetes

Journal of Cellular Physiology, 2019
Dysfunction of the adipose tissue is a central driver for obesity‐associated diabetes. It is characterized by dysregulated adipokine secretion, which contributes to insulin resistance of key metabolic tissues, including the liver, skeletal muscles, and ...
Bo Zhang   +4 more
semanticscholar   +1 more source

Adipokines in Obesity

2008
Adipose tissue is the source of soluble mediators (adipokines), secreted mainly by adipocytes. Leptin acts on the brain and peripheral organs to regulate energy homeostasis and the neuroendocrine axis. Adiponectin regulates glucose and lipid metabolism by targeting the liver and skeletal muscle.
Rexford S, Ahima, Suzette Y, Osei
openaire   +2 more sources

Adipokines in bone disease

Nature Reviews Rheumatology, 2016
Adipose tissue secretes highly bioactive factors, the adipokines. Systemic levels of adipokines are often altered in the presence of inflammation. In turn, adipokines affect different tissues and cells systemically as well as locally, contributing to immunomodulatory and bone remodelling mechanisms.
Elena, Neumann   +4 more
openaire   +2 more sources

Renal Handling of Adipokines

2006
Chronic kidney disease (CKD) is now considered as one of the strongest risk factors for all cause mortality and cardiovascular events. However, the link between CKD and systemic events is unclear. The role of the kidney is primarily considered a target organ during the development of obesity as altered production of adipokines from visceral adipocytes,
Hitomi, Kataoka, Kumar, Sharma
openaire   +2 more sources

Adipokines in Childhood Obesity

2013
The worldwide increase in the prevalence of obesity in children and adolescents during the past decades, in addition to mounting evidence indicating that obesity is associated with an increased incidence of comorbidities and the risk of premature death, resulting in a high economical impact, has stimulated obesity-focused research.
Gabriel Ángel, Martos-Moreno   +3 more
openaire   +2 more sources

Adipokines and Alzheimer's Disease

2011
Alzheimer's disease pathology involves β-amyloid and tau. Various potential pharmacological targets are discussed that may be able to alleviate the accumulation of β-amyloid and tau. Possible causes of Alzheimer's disease are discussed involving impaired glucose and lipid metabolism and obesity. Adipokines may be involved in the etiology of Alzheimer's
SORTINO, Maria Angela   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy